MICHAEL HOAGLAN: Open Payments
NPI 1326475682 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 7 payments from 6 companies in 2025. Trend: 2023 $107 · 2024 $78 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $32 |
| Caris MPI, Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $26 |
| Incyte Corporation | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
| SpringWorks Therapeutics, Inc. | 1 | $17 |
Products named: Lenvima, MI CANCER SEEK, AYVAKIT, MONJUVI, TEFLARO, GOMEKLI.
Industry payments across MD — which companies pay providers there.
